CME Group Stock Price and Value Analysis

Should you buy CME Group stock? (NasdaqGS:CME). Let's see how it does in our automated value investing analysis system.

  • This company has an average dividend yield.
  • This company is very stable.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This stock looks overpriced.

Inside the CME Numbers

CME Price
(CME Group stock price per share)
[?] CME Fair Price
(based on intrinsic value)
[?] CME Safety Price (based on a variable margin of safety) $80.78
[?] PE Ratio versus Sector 143% higher than other Financial stocks
[?] PE Ratio versus Industry 48% lower than other Unknown stocks
[?] Cash Yield 2.82%
[?] Free Cash Flow Jitter 46%
[?] Dividend Yield 2%
Shares Shorted 4,366,597

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 4,366,597 shares shorted. With 357,326,773 shares available for purchase and an average trading volume over the past 10 trading days of 2,509,270, it would take at least 1.74 days for all of the short holders to cover their shorts.

Is CME Group Stock on Sale?

We believe that CME Group may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

CME Group looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CME Stock?

Does CME Group have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.